Instrument Business Outlook Volume 32 - Issue 20

3 Feb 2024

Categories:

Instrument Business Outlook

Table of Contents

Private Equity Lab Tool Deal Values Fall in 2023
- Cell Analysis Stands Out
- Other Popular Investments
- Series Leaders
- Top Investors
- Geographic Counts
- Uncertainty Slows 2023 Dealmaking
- 2024
Executive Briefing
- NanoString Pursues Strategic Alternatives
- UK Competition Authority Requests Comments on Thermo-Olink
- Bruker Buys Automation Firm
- Mettler-Toledo Suffers Fourth Quarter Sales Shortfall
- Datacolor to Delist Shares
- Calibre Invests in Swiss Company
IBO Stock Indexes Perform Tepidly in January
- Laboratory Instruments and Products Stock Index
- Diversified Instrumentation Stock Index
- International Stocks
Market Profile: Electron Paramagnetic Resonance Spectroscopy
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Healthcare: VC Investments Decline
- Biopharma: Total M&A Value Robust in 2023
- Cell and Gene Therapy: Capacity Bottlenecks
Region Watch
- China: Economy Jeopardizes S&T Spending
- Germany: Biotech Outlook Improves Slightly
- EU: IVD Compliance Update
News
- Broad-Based Companies
  - Company Announcements
  - Product Introductions
- Sequencing
  - Company News
  - Product Introductions
  - Sales & Orders of Note
- Life Science Instruments
  - Product Introductions
  - Gene-Based Analysis
  - Product Introductions
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Materials Characterization
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
Bottom Line

Attachments

IBO 020224 Issue.pdf